Nhau dzeKambani
Kurapa kweCAR-T muB-cell Acute Lymphoblastic Leukemia Kunoratidza Kushanda Kusina Kumboitika
Ongororo itsva inoratidza kushanda kunoshamisa kweCAR-T cell therapy mukurapa B-cell Acute Lymphoblastic Leukemia (B-ALL). Tsvakurudzo iyi, inosanganisira kushanda pamwe chete neBIOOCUS neLu Daopei Hospital, inoratidza kufambira mberi kukuru, zvichiratidza kuti kurapa uku inzira yakakosha yekurapa.
Kurapa Kwemasero eCAR-T Kunochinja Kurapa Kwezvirwere Zvikuru zveMaseru eB
Vatsvaguriri vekuLu Daopei Hospital nevamwe vanoshanda navo pasi rose vanoongorora nzira dzekurapa dzeCAR-T cell dzemazuva ano, vachipa tariro kune varwere vane B cell mongernancies. Chidzidzo ichi chinoratidza kufambira mberi mukugadzirwa uye mashandisirwo azvo, zvichiratidza mhedzisiro yakanaka uye mukana wekuvandudza mune ramangwana.
Kubudirira Kwakawedzerwa Kwekudzivirira Tumor kwe4-1BB-Based CD19 CAR-T Cells mukurapa B-ALL
Zvidzidzo zvekiriniki munguva pfupi yapfuura zvinoratidza kuti masero eCD19 CAR-T ane 4-1BB anoratidza kushanda zvakanaka kwekudzivirira bundu zvichienzaniswa nemasero eCAR-T ane CD28 mukurapa B cell inodzokera shure kana kuti isingadzoreki acute lymphoblastic leukemia (r/r B-ALL).
Kurapa kweLu Daopei kweCD19 CAR-T kwaratidza mhedzisiro yakanaka muvarwere veB-ALL
Ongororo yakaitwa munguva pfupi yapfuura paLu Daopei Hospital yakaratidza kushanda zvakanaka uye kuchengetedzeka kwekurapa kweCD19 CAR-T cell therapy ine dose shoma mukurapa varwere veB acute lymphoblastic leukemia (B-ALL) vasina simba kana kuti vakadzokera shure. Ongororo iyi, iyo yaisanganisira varwere makumi mashanu nerimwe, yakaratidza mwero wekurerukirwa kwakazara uye migumisiro mishoma.
Nzira Itsva Yekukurudzira Inosimudzira Kuchengetedzeka uye Kushanda Kwekurapa kweCAR-T MuAcute B Cell Leukemia
Chipatara cheLu Daopei neHebei Senlang Biotechnology vazivisa zvakawanikwa zvinovimbisa kubva muongororo yavo yazvino pamusoro pekuchengetedzeka uye kushanda kwekurapa kweCAR-T pakurapa B cell leukemia. Kushanda pamwe uku kunoratidza mukana wekugadzirwa kweCAR-T cell itsva kusimudzira mhedzisiro yevarwere.
Chidzidzo Chebudiriro Chinoratidza Kuchengetedzeka uye Kushanda Kwekurapa kweCAR-T Mukurapa Maronda eB-Cell
Chidzidzo chitsva chakatungamirwa naDr. Zhi-tao Ying wekuPeking University Cancer Hospital chakaratidza kuchengetedzeka uye kushanda kweIM19 CAR-T cell therapy mukurapa kenza yeropa yeB-cell inodzokera shure uye isingadzoreki. Chakaburitswa mu Chinyorwa cheChinese cheMishonga Mitsva, chidzidzo ichi chinoshuma kuti varwere gumi nerimwe pagumi nevaviri vakawana zororo rakazara vasina migumisiro yakaipa, zvichiratidza mukana weIM19 senzira yekurapa ine tariro kune varwere vane dzimwe nzira shoma.
Kudzidziswa Kwegore Negore Kwekutarisira Ropa Nekushandisa Tekinoroji Kunoitirwa kuYanda Ludaopei Hospital
Kudzidziswa Kwegore Negore kwa2024 kweKutarisira Ropa muSanhe City kwakaitwa zvinobudirira kuYanda Ludaopei Hospital. Chiitiko ichi chakanangana nekusimudzira kutarisirwa kweropa muchipatara uye kuchengetedzwa kweropa kuburikidza nekudzidziswa kwakazara kwakapindwa nenyanzvi dzehutano dzinopfuura zana kubva kumasangano akasiyana-siyana ekurapa.
Kukurudzira Hutano uye Kupora: Kutarisirwa Kwezuva Nezuva Kwevarwere VeLeukemia
Kuona kuti varwere vane leukemia vanorapwa zvakachengeteka uye zvinonyaradza kunosanganisira kutarisirwa kwakanyatsonaka kwezuva nezuva, kusanganisira kucheneswa kwezvakatipoteredza, hutsanana, kudya kunovaka muviri, uye kurovedza muviri kwakakodzera. Gwaro iri rinopa mazano akakosha ekutarisira zuva nezuva zvinobudirira kuti vatsigire kupora.
Kurapa Masero eNS7CAR-T Kunoratidza Chipikirwa Chekurapa R/R T-ALL/LBL
Ongororo ichangobva kuitwa inoratidza kushanda zvakanaka uye kuchengetedzeka kweNS7CAR-T cell therapy mukurapa recurrent kana refractory T-cell acute lymphoblastic leukemia (R/R T-ALL) uye T-cell lymphoblastic lymphoma (R/R T-LBL). Kurapa uku kunopa tariro itsva kuvarwere vane mhando idzi dzegomarara.
Kuzivisa 2024 Annual Lu Daopei Hematology Forum muna Nyamavhuvhu
Musangano wegore negore wechi12 weLu Daopei Hematology Forum wakarongwa kuitwa kubva musi wa23-24 Nyamavhuvhu, 2024, paBeijing International Convention Center. Tibatanei kuti muwane hurukuro dzinopa ruzivo rwakadzama uye kufambira mberi kwazvino mu hematology.
Kuvhurwa kweASH kwa2023 | Dr. Peihua Lu Anopa CAR-T yeRelapsed/Refractory AML Research
